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Abstract
Background: Laser acceleration of protons and heavy ions may in the future be used in radiation therapy. Laser-
driven particle beams are pulsed and ultra high dose rates of >10
9 Gy s
-1may be achieved. Here we compare the
radiobiological effects of pulsed and continuous proton beams.
Methods: The ion microbeam SNAKE at the Munich tandem accelerator was used to directly compare a pulsed
and a continuous 20 MeV proton beam, which delivered a dose of 3 Gy to a HeLa cell monolayer within < 1 ns or
100 ms, respectively. Investigated endpoints were G2 phase cell cycle arrest, apoptosis, and colony formation.
Results: At 10 h after pulsed irradiation, the fraction of G2 cells was significantly lower than after irradiation with
the continuous beam, while all other endpoints including colony formation were not significantly different. We
determined the relative biological effectiveness (RBE) for pulsed and continuous proton beams relative to x-
irradiation as 0.91 ± 0.26 and 0.86 ± 0.33 (mean and SD), respectively.
Conclusions: At the dose rates investigated here, which are expected to correspond to those in radiation therapy
using laser-driven particles, the RBE of the pulsed and the (conventional) continuous irradiation mode do not differ
significantly.
Keywords: laser acceleration, proton therapy, dose rate effects
Background
Because of the superior dose distribution of protons and
heavy ions, radiotherapy using charged particles has
attracted increasing interest over the last years [1,2]. At
the same time, however, a vivid discussion has started as
to whether the potential improvements in outcome justify
the costs of particle therapy, where the costs per fraction
are estimated to be up to 5 times higher than those for
photon therapy [3]. With the advent of ultrafast high
energy lasers, the idea of laser-driven acceleration of parti-
cles suitable for therapeutic applications has arisen, com-
bined with the hope for a reduction of costs and required
s p a c e[ 4 - 6 ] .W h i l ee a r l yc o n c e p t sm a yh a v eb e e nab i t
over-enthusiastic [7], recent feasibility studies still see a
potential for laser-acceleration in radiation therapy [8-10],
although the energies achieved at present are far from
those required for radiation therapy and many questions
remain unresolved, e.g. regarding energy selection, beam
preparation and transport, as well as repetition rate.
With respect to potential differences in the radiobiologi-
cal effects of laser-accelerated particles and those acceler-
ated conventionally by cyclotrons or synchrotrons, the
main difference is that particle beams delivered from laser
acceleration will be pulsed. While the laser pulses required
for the acceleration of high energy particles are in the
range of femtoseconds, the particle pulse thus created will
spread in time during beam transport. For example,
assuming protons with a mean energy of 100 MeV and an
energy spread of 1% which are transported over a 20 m
distance, the expected duration of the pulse at the target
will be about 1 ns [11]. Since the repetition rates of laser
accelerators are expected to be rather moderate, one can
envision that during one session each voxel of the PTV
(planning treatment volume) can be targeted at most a
few times if the treatment duration is to be kept reason-
ably short. Thus, with one pulse a considerable fraction of
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any medium, provided the original work is properly cited.the required dose at a target voxel has to be given. Assum-
ing a deposition of >1 Gy in 1 ns, this translates to an ultra
high dose rate of >10
9 Gy s
-1.
In the past, radiobiological effects of x-ray or electrons
delivered at ultra high dose rates were reported: Several
authors described an enhanced resistance of cells irra-
diated with several Gy at dose rates in the range of 10
9
Gy s
-1 at low oxygen concentrations [12,13] which was
ascribed to oxygen depletion. Radical-radical recombina-
tion was also proposed as a possible explanation for
reduced efficiency of pulsed irradiation [14]. It should
be noted that these previous experiments were per-
formed with conventional acceleration. Currently avail-
able laser accelerators have so far allowed for the
performance of a few proof-of-principle experiments
with laser plasma-generated X-rays [15,16] and ultra-
soft X rays [17]. Tillmann and coworkers [15] applied a
dose of only 3.4 mGy per 2 ps pulse, which at repetition
rates of 10 Hz lead to effective dose rates in the range
of 2 Gy min
-1. Hill and coworkers [17] achieved 0.07 Gy
p e r1 0p sp u l s e ,i . e .w i t h7×1 0
9 Gy s
-1 ad o s er a t e
where high dose rate effects may occur. Finally, Shino-
hara and coworkers [16] achieved up to 8 Gy per single




None of these authors found indications for significant
effects of the dose rates associated with laser plasma-
generated X-rays as compared to conventional irradia-
tions on cell survival. However, the photon beams used
for comparison differed in all three cases in terms of
mean energy and energy distribution, so that in the case
of small alterations it would be difficult to determine if
these are due to differences in dose rate or in energy
spectrum. Recently, also proof-of-principle experiments
with laser driven protons or electrons were performed,
in which it was shown that these beams generate DNA
double-strand breaks, as would have been expected
[18-20]. A quantitative evaluation and comparison with
conventionally accelerated protons was, however, not
provided.
In order to simulate the pulsed irradiation conditions
expected for laser-accelerated protons in therapy settings,
we have established a pulsed proton beam at the ion
microbeam SNAKE at the Munich tandem accelerator
[11]. By focusing a bunch of 10
5 p+ onto a spot of
approximately 100 μm × 100 μm we apply macroscopic
doses of a few Gy within <1 ns. The irradiations are per-
formed with monoenergetic protons, which enables us to
perform irradiations with conventional dose rates for
direct comparison with the same beam quality. Using this
system, in previous work we reported that the induction
of micronuclei in HeLa cell monolayers or in keratinocytes
within 3D tissue is not significantly different between
pulsed and conventional proton irradiation [21,22]. In an
analysis of chromosome aberrations, however, we found
evidence that proton irradiation in the pulsed mode may
be slightly less effective than in the continuous irradiation
mode [23]. Here we extend these studies to the analysis of
radiation induced cell cycle arrests and apoptosis. In addi-
tion, and most importantly, we also investigate the clono-
genic survival of cells irradiated under both conditions.
This endpoint is generally considered to be of utmost rele-
vance when judging irradiation conditions.
Methods
Cell culture for irradiation
HeLa cells (subtype HeLa-RIKEN) were cultured in RPMI
TS 1640 medium (PAA), supplemented with 10% fetal
bovine serum, 2 mM L-glutamine, 100 U/ml penicillin,
and 50 μg/ml streptomycin in a humidified incubator (5%
CO2, 37°C). Twelve hours prior to irradiation, cells were
seeded in stainless steel cell containers designed for irra-
diation at SNAKE [24]. In these containers, cells grow on
a6μm thick Mylar foil (carrier foil), covered with Cell-
TAK™ Tissue Adhesive (BD Biosciences) for better
attachment. In order to provide restricted growth areas in
these containers, two different cylindrical adapters can be
mounted onto the container. The growth areas thus
obtained are 3.14 cm
2 for 2 × 10
5 cells in immunofluores-
cence experiments, or 0.65 cm
2 for 3 × 10
4 cells in clono-
genic survival experiments. Since the irradiation setup at
SNAKE requires a vertical sample position, the adapters
were removed from the incubator directly before treat-
ment and the containers were sealed with another Mylar
foil glued to a stainless steel lid. During irradiation, which
takes less than 10 min, the cells are not covered by med-
ium, but a medium reservoir ensures a humid atmosphere.
After irradiation cells were given fresh medium and they
were incubated for 0 to 48 hours until fixation for immu-
nofluorescence. For clonogenic survival experiments the
cells were harvested one hour after radiation treatment
and appropriate numbers of cells were reseeded in 6-well
tissue containers. The same cell cultivation procedures
and same containers were used in proton irradiation and
X-ray experiments.
Irradiation with 250 kV X-rays
X-ray irradiation was performed with a Philips MCN-ray
tube (250 kV, 13 mA, 2.5 + 4.0 mm Al and 1.0 mm Cu fil-
tration) at a dose rate of 0.56 Gy min
-1. HeLa cells grown
on Mylar foil were irradiated with doses from 0 to 5 Gy
for a reference survival curve (2 independent experiments)
and with 3 Gy for immunofluorescence detection of cell
cycle arrest and apoptosis (5t o7i n d e p e n d e n te x p e r i -
ments, each with a non-irradiated control).
Irradiation with pulsed and continuous proton beams
Proton irradiation was performed using the microprobe
SNAKE at the Munich tandem accelerator in a pulsed
Auer et al. Radiation Oncology 2011, 6:139
http://www.ro-journal.com/content/6/1/139
Page 2 of 8and a continuous irradiation mode. Beam preparation
and dosimetry [11], as well as cell irradiation with
pulsed and continuous proton beams at SNAKE [21]
were performed as described previously. For pulsed irra-
diations, about 10
5 protons were focused onto a beam
spot of approximately 100 × 100 μm
2,w h i c hw a st h e n
scanned with 100 Hz over a region of 1.5 × 2 mm
2 for
immunofluorescence staining experiments. This scan-
ning results in a nearly homogeneous dose distribution,
where between 25% and 60% (on average nearly 50%) of
the total dose (3 Gy) to each cell was given by a single
< 1 ns pulse, corresponding to an instantaneous dose
rate of > 10
9 Gy s
-1, while the remaining dose resulted
from contributions of adjacent irradiation fields. In col-
ony formation experiments larger irradiation fields were
required in order to entirely cover the circular cell culti-
vation area of 0.65 cm
2. Therefore, a region of approxi-
mately 10 mm × 10 mm was irradiated by arranging
several 1.5 × 2.0 mm
2 fields next to each other by mov-
ing the cell sample mechanically. In irradiations with
the continuous beam, a rectangular beam spot with a
size of approximately 2 × 2 mm
2 was used, and the time
required to deliver the total dose to cells was in the
order of 100 ms (dose rate ~30 Gy s
-1).
Experiments for detection of cell cycle arrest and apopto-
sis were performed with 20 MeV protons (LET in water
2.648 keV µm
-1. For colony formation, the proton energies
were varied between 20 and 25 MeV between experiments
for technical reasons. Dose was changed by adjusting the
proton fluence accordingly. The variation in LET (between
2.648 keV μm
-1 and 2.207 keV um
-1) was considered to be
negligible.
Parallel irradiation experiments with pulsed and contin-
uous beams were always conducted within the same beam
time, but for technical reasons they had to be separated by
2-3 days, i.e. the time needed to switch from pulsed to
continuous beam preparation.
Immunofluorescence detection of cell cycle arrest and
apoptosis
For immunofluorescence analyses, cells were fixed with 2%
paraformaldehyde (PBS-buffered; 15 min) immediately
after the irradiation experiment (i.e. on average about 5
min after irradiation, due to the duration of the irradiation
and the sample handling) or after incubation for 10, 24, or
48 hours. Permeabilisation (0.15% TritonX 100 in PBS)
and blocking (1% BSA, 0.15% Glycine in PBS) were done
as described previously [24]. Epifluorescence microscopy
was performed with a Zeiss AxioObserver Z1 inverse epi-
fluorescence microscope (Germany), using a Zeiss LCI
Plan Neofluar 63/1.3 objective, the software AxioVision
4.6 and an AxioCam Mrm camera (Zeiss). All images were
further processed using the software ImageJ 1.37c (http://
www.uhnresearch.ca/wcif).
Cells in G2/M phase were identified by immunostaining
with mouse anti-CyclinB1 antibody (dilution 1:100,
Abcam #ab49215). G2-specific staining was in initial
experiments verified by co-staining with rabbit anti-
CENP-F antibody (1:500, Novus Biologicals, #NB500-101),
which identifies cells in S/G2/M phase. In cell samples
irradiated with protons, the irradiated region was detected
by co-staining with rabbit anti-g-H2AX antibody (1:200,
Abcam, # ab11174). After application of fluorescence con-
jugated secondary antibodies sheep-anti-mouse Cy3
(1:500, Dianova, #515-165-062) and goat-anti-rabbit
Alexa488 (1:200, Molecular Probes, #A-11034), DNA was
stained with DAPI. The fraction of CyclinB1 positive cells
(excluding mitotic cells as identified by chromatin struc-
ture), was separately determined for the irradiated area
and a non-irradiated area (n. i.) of the same sample. The
data presented give the mean and standard error of the
mean (SEM) of 3 independent proton experiments
performed within 3 different beam times and 5 to 7 inde-
pendent x-ray experiments.
Apoptotic cells were initially identified by staining with
rabbit anti-cleaved caspase3 (1:100, Trevigen, #2305-PC-
050) and goat-anti-rabbit Alexa488 (1:200, Molecular
Probes, #A-11034). DNA was stained with DAPI. Since
the same results were obtained when identifying apoptotic
cells based on the characteristic chromatin structure after
DAPI staining, in later experiments the apoptotic cells
were identified simply by chromatin structure. In samples
irradiated with protons, the irradiated area was detected
by immunostaining with rabbit anti-g-H2AX antibody
(1:200, Abcam, # ab11174). The percentage of apoptotic
cells was determined in 2 to 5 proton experiments per
point of time, performed within 4 different beam times,
and 5 to 7 independent x-ray experiments (mean and
SEM).
FACS analysis of cell cycle distribution
For quantitation of cells in G2/M phase by FACS analysis,
cells were harvested 10 and 24 hours after irradiation with
x-rays (3 Gy and sham-irradiated controls) and washed
with PBS. Cells were resuspended in 0.5 ml DNA-staining
solution I (PBS containing 10 μg/ml RNAse, 0.6 mg/ml
NaCl, 1 mg/ml Sodium citrate, 0.07% Nonidet
® P4 0S u b -
stitute, 20 μg/ml propidium iodide (PI)) and incubated at
room temperature in the dark for 30 min, before 0.5 ml of
ice-cold DNA-staining solution II (PBS containing 15 μg/
ml citric acid, 85 μg/ml sucrose, 20 μg/ml PI) was added.
Samples were stored at 4°C until PI-detection with BD
FACSCanto™. Data were analysed with BD FACSDiva™
software.
Clonogenic survival
About 24 h prior to irradiation, 3 × 10
4 HeLa cells were
seeded in irradiation containers on Mylar foil, restricted
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2 by a special cylindrical adapter.
To characterize survival after irradiation with pulsed
and continuous protons, we have chosen a dose of 3 Gy,
analogous to the other investigated endpoints. For creat-
ing a reference survival curve, cells were irradiated with
250 kV x-rays, with doses ranging from 0 to 5 Gy. One
hour after irradiation, cells were harvested by trypsina-
tion and counted with a Bürker chamber. Cells were
reseeded in 3 different titres and in triplicates into
6-wells containers. The cells were maintained at 37°C
and 5% CO2 for 10 days to allow colony formation.
After this time period, the cells were fixed and stained
with ethanol (80%) containing 0.3% methylene blue for
30 minutes. After washing, the samples were air-dried
and microscopically examined. Colonies consisting of
more than 50 cells were considered as survivors. The
plating efficiency (PE = cells seeded/colonies counted)
was calculated for non-irradiated cells and the surviving
fraction of irradiated cells (SF = [cells seeded/colonies
counted]/PE) was determined. Each experiment was per-
formed at least twice and mean and standard deviation
(SD) are presented.
The RBE of protons (pulsed or continuous) is calcu-
lated as the ratio between the dose, Dg, of the reference
radiation (250 kV X-rays) and the dose, Dp, of protons
which produced equal response, y: RBE = Dg/Dp. To
calculate Dg the measured dose response curve is para-
meterised by a linear-quadratic function y = c + aD+
bD2, fitted to determine the parameter c, a and b and
inverted.
As the fit parameters, c, a and b, depend on each other,
a Monte Carlo simulation-based Bayesian data analysis is
performed. In a first step the three-dimensional probabil-
ity density is calculated as a function of c, a and b for
measuring the data set used for the dose response curve.
In a second step, assuming a Gaussian probability density
for y, the probability density for Dg is calculated leading
to the confidence interval for Dg. From this and from the
error of the proton dose measurement the error of the
RBE value is calculated by Gaussian error propagation.
Results
Experimental Set-up
In order to apply macroscopic doses of a few Gy within
1 ns, we use a proton microbeam facility with which 10
5
p+ can be focused onto a spot of approximately 100 μm
×1 0 0μma n dd e l i v e r e dw i t h i n0 . 9n s[ 1 1 ] .T h i sb e a m
spot is scanned over a larger area to irradiate a sufficient
number of cells. In our first experiments, the irradiated
field was for technical reasons limited to 1.5 × 2 mm
2.
Since this irradiated field is surrounded by a large area
(diameter ~3 cm) of unirradiated cells, only biological
endpoints amenable to a microscopic evaluation could
thus be investigated. We chose microscopic analysis of
cell cycle distribution and of apoptosis induction. The
irradiated field is identified by concomitant immuno-
fluorescence detection of DNA damage markers such as
g-H2AX or 53BP1.
In later experiments, including experiments on colony
formation ability, the field size was increased to 10 × 10
mm
2 by introducing additional mechanical scanning of
the cell sample. Analysis of colony formation required
that all cells on the dish were irradiated before harvest
and reseeding. We therefore devised specific cylindrical
adaptors with which the growth field on the Mylar foil
could be clearly defined. Cells were seeded within this
cylinder (9 mm diameter) and allowed to grow and form
a sub-confluent layer there. Immediately before the irra-
diation, the cylinders were removed. For irradiation, the
cell field was aligned to the beam by using an optical
microscope.
Cell cycle arrest
Cyclin B1 expression begins in S phase and peaks in G2
phase. Prior to M phase, cyclin B1 is predominantly
located in the cytoplasm; after centrosome separation it
accumulates in the nucleus, before it is degraded at the
transition of meta- to anaphase. Radiation-induced G2
arrest and relative cyclin B1 expression were shown to
correlate well in Hela cells [25]. To test the correlation
between DNA content and microscopically detectable
cyclin B1 localization in cytoplasm or nucleus, parallel
samples were subject to PI staining and flow cytometry,
or to immunofluorescence with cyclin B1 staining (Addi-
tional file 1). A clear accumulation of G2/M phase cells is
detected 10 h after irradiation (3 Gy x-ray) in irradiated
cells, while after 24 h the percentage of G2/M cells in
irradiated samples returned to a level similar to unirra-
diated controls. When mitotic cyclin B negative cells,
which were identified microscopically by the typical chro-
matin appearance, were added to the numbers of cyclin
B1 positive cells, both methods gave very similar results,
demonstrating that microscopic determination of cyclin
B1 staining can be used to determine G2 phase cells.
To compare the induction of G2 arrest in cells irra-
diated by 3 Gy pulsed and continuous proton irradiation,
the cells were irradiated under the respective conditions,
and fixed at the earliest time point amenable (on average
about 5 min) or, after removal of the lid and medium
exchange, incubated for 10 h, 24 h, or 48 h at 37°, 5%
CO2 before fixation. Samples were simultaneously
stained for cyclin B1 to determine the cell cycle position
and g-H2AX to identify the irradiated field. Typical
examples are shown in Figure 1. The proportion of G2
phase cells (defined as cyclin B1 positive, without mitotic
cells) among cells exhibiting damage markers was
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experiment. After proton irradiation the maximum G2
phase arrest is evident after 10 h, while after 24 h the
proportion of G2 phase cells is similar to the situation
before irradiation (Figure 2). Interestingly, at 10 h after
irradiation the proportion of G2 phase cells after contin-
uous proton irradiation was found to be significantly
higher than after pulsed irradiation (t-test, two-tailed p =
0.0182). To test whether the difference can be explained
by small differences in absolute dose between the sam-
ples irradiated at pulsed and continuous mode, we asked
whether a substantial increase in dose would affect the
outcome and compared the induction of G2 phase arrest
after x-irradiation of HeLa cells with 3 and 5 Gy (Addi-
tional file 2). Since the fraction of G2 phase cells after 10
h is practically the same at both doses, we conclude that
the differences between pulsed and continuous mode
cannot be explained by small variations in dose. We note
that the duration of the G2 phase arrest appears to be
influenced by dose.
Figure 1 Detection of G2 phase cells by cyclinB1 staining. Immunofluorescence detection of cyclin B (red) 10 h (left) and 48 h (right) after
continuous proton irradiation (3 Gy) and sham irradiation. Irradiated cells are identified by g-H2AX staining (green). Apoptotic cells (white arrows)
and mitotic cells (yellow arrows) are identified by their appearance after DAPI staining (blue).
Figure 2 Accumulation of cells in G2 phase after irradiation.
Cells were irradiated with protons (3 Gy) in pulsed mode (P) or
continuous mode (C). Data are from 3 independent experiments,
except for irradiated (3 Gy) sample at 0 h (1 experiment). Indicated
are means and standard errors of the mean (SEM).
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Since the number of samples that can be irradiated at
SNAKE is very limited, we aimed at determining the
induction of apoptosis in the samples used for determina-
tion of G2 arrest. In preliminary experiments we verified
by co-staining with an antibody recognizing the apoptosis
indicator, cleaved caspase 3, that apoptotic cells can be
identified after DAPI staining by the appearance of bright
circular bodies (Additional file 3). After irradiation with x-
rays, the proportion of apoptotic cells increases with time,
but the inter-experimental variation is very high (Addi-
tional file 4). One likely explanation is that in the course
of the immunofluorescence detection, which involves sev-
eral washing steps, apoptotic cells can easily be lost. Com-
paring induction of apoptosis after proton irradiation in
the continuous mode and the pulsed mode, no significant
difference was seen (Figure 3).
Colony formation
Colony formation is one of the most important endpoints
in studying radiobiological effects. After irradiation with 3
Gy using pulsed and continuous proton beams, the frac-
tion of colony forming cells was 0.43 ± 0.07 (mean and
SEM) and 0.47 ± 0.06, respectively. This difference is not
statistically significant. For comparison the survival curve
after x-irradiation is also shown (Figure 4). We determined
the relative biological effectiveness (RBE) for pulsed and
continuous proton beams relative to x-irradiation as 0.91
± 0.26 and 0.86 ± 0.33 (mean and SD), respectively. These
values are not significantly different.
Discussion
The present work is part of a series of systematic com-
parisons of biological endpoints after irradiation with
pulsed and continuous proton beams, which in their dose
rate differ by a factor of 10
8. Using Monte Carlo-based
modelling, Kreipl et al. conducted a systematic analysis of
the impact of spatial and temporal proximity of ion
tracks on the yield of hydroxyl radicals [26]. While
indeed the yield of hydroxyl radicals is expected to be
reduced when two ion tracks overlap closely in time and
space, the authors conclude that at typical doses asso-
ciated with radiation therapy (2 - 5 Gy), the spatial
separation of two tracks is larger than would be necessary
for the reduction in hydroxyl radical yield to occur. This
holds for proton tracks, and even more so for heavier
ions. Indeed, in our previous analyses we did not detect
statistically significant differences between both irradia-
tion modes when investigating a variety of specific end-
points related to chromosomal damage, i.e. micronuclei
and chromosomal aberrations [21-23]. We consistently
observed, however, a slightly reduced apparent efficiency
of the pulsed beam in inducing the damage compared to
the continuous beam. When combining data for different
types of chromosomal aberrations (dicentrics, centric
rings and excess acentrics) and thus increasing the sam-
ple size, we recently observed a statistically significantly
reduced effectiveness of pulsed irradiation [23].
Here, we report for the first time a reduced effectiveness
of the pulsed irradiation mode on a single endpoint,
namely G2 phase arrest at 10 h after irradiation (Figure 2),
thus substantiating the previous observations. This
Figure 3 Induction of apoptosis after irradiation. Cells were
irradiated with protons (3 Gy) in pulsed mode (P) or continuous
mode (C). Data are from 5 independent experiments except for
data at 10 h (4 experiments) and irradiated samples at 0 h (2
experiments). Indicated are means and standard errors of the mean
(SEM).
Figure 4 Colony formation after irradiation with pulsed and
continuous proton beams. Indicated is relative survival (surviving
fraction, SF) of HeLa cells after irradiation with pulsed (SF P, open
square) or continuous (SF C black square) proton beams at 3 Gy.
Mean and SD of 3 independent experiments in 3 different beam
times. Reference: x-ray irradiation (SF X, black triangles), mean and
SD of 2 independent experiments.
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of cell arresting in G2 appears to be rather insensitive to
dose, at least in the dose range of 3 to 5 Gy x-irradiation
(Additional file 2). While exhibiting a high degree of varia-
tion, we find indications that the duration of the G2 arrest
may be longer after irradiation in the pulsed mode than in
the continuous mode (Figure 2), possibly hinting at a shift
in the time to maximum G2 arrest and in duration.
Further experiments are necessary to clarify this point. We
cannot exclude at present that the observed difference
reflects differences in damage complexity, as it is well
known that the duration of the G2 arrest is affected by
LET [27]. There is no evidence that systematic errors in
dosimetry had influence on this result, because the same
setup was used for preparation of the pulsed and the con-
tinuous beam for proton irradiation.
In any case, the difference in cell cycle response did not
translate into a difference in colony forming ability
(Figure 4). While the pulsed beam was slightly more effi-
cient in cell killing, the difference was not significant.
With 0.91 ± 0.26 and 0.86 ± 0.33 for pulsed and continu-
ous mode, respectively, and considering that x-rays were
used as reference irradiation rather than gamma rays, the
RBE determined for both irradiation modes is compatible
with the generally assumed RBE of 1.1, which is also
applied in proton therapy [28]. We cannot exclude at the
moment that at even higher dose rates in pulsed mode,
differences would become apparent.
While production of ultra high dose rate pulses emerges
as an interesting new application of microbeams that can
even be used for irradiation of mice [29,30], the dose rates
achievable with our set-up are limited. Experiments to
investigate the effects of laser-driven protons, which
would deliver their dose in the ps range if the distance
between proton source and cell targets is not too large, are
currently under way in our laboratory. It is important to
note, however, that in a clinical application of laser-driven
protons, the proton source is also expected to be not very
close to the patient, since high levels of unspecific dose
distributions from primary and secondary neutron and
high energy x-ray fields and the need for selection of pro-
tons with appropriate energy from the broad energy distri-
bution typically obtained by laser acceleration will require
a beam line which for radiation protection reasons may
not be much shorter than the beam lines known from
conventional acceleration. We currently estimate the pulse
duration at the tumor voxel in the range of 1 ns [11].
Conclusion
At the dose rates investigated here, which are expected to
correspond to those in radiation therapy using laser-driven
particles, the RBE of the pulsed and the (conventional)
continuous irradiation mode do not differ significantly.
Additional material
Additional file 1: Agreement of quantitative determination of G2/M
phase cells by FACS analysis and microscopy. This figure shows the
results of a quantitative evaluation of the number of G2/M phase cells
determined by FACS analysis and microscopy in parallel samples.
Additional file 2: Dose-dependence of accumulation of cells in G2
phase after x-irradiation. This figure shows the frequency of cells in G2
phase after irradiation with 0, 3 and 5 Gy and incubation for 0, 10, 24
and 48 h.
Additional file 3: Microscopic identification of apoptotic cells. This
figure shows examples of apoptotic cells identified by staining for
cleaved caspase 3 and by appearance after DAPI staining.
Additional file 4: Dose-dependence of induction of apoptotic cells
after x-irradiation. This figure shows the frequency of apoptotic cells
after irradiation with 0, 3 and 5 Gy and incubation for 0, 10, 24 and 48 h.
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